A Pilot Study of Intravenous Topotecan and Vincristine in Combination With Subconjunctival Carboplatin for Patients With a History of Bilateral Retinoblastoma and Refractory/Recurrent Intraocular Disease (IND 104,942).

Trial Profile

A Pilot Study of Intravenous Topotecan and Vincristine in Combination With Subconjunctival Carboplatin for Patients With a History of Bilateral Retinoblastoma and Refractory/Recurrent Intraocular Disease (IND 104,942).

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Carboplatin (Primary) ; Topotecan (Primary) ; Vincristine (Primary) ; Filgrastim
  • Indications Retinoblastoma
  • Focus Therapeutic Use
  • Acronyms RELRB1
  • Most Recent Events

    • 28 Feb 2017 Planned End Date changed from 1 Mar 2015 to 1 Mar 2012.
    • 28 Feb 2017 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2012.
    • 28 Feb 2017 Status changed from recruiting to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top